These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2165168)

  • 1. Conditions required for the bactericidal activity of 4-quinolones against Serratia marcescens.
    Lewin CS; Smith JT
    J Med Microbiol; 1990 Jul; 32(3):211-4. PubMed ID: 2165168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smaqnr, a new chromosome-encoded quinolone resistance determinant in Serratia marcescens.
    Velasco C; Rodríguez-Martínez JM; Briales A; Díaz de Alba P; Calvo J; Pascual A
    J Antimicrob Chemother; 2010 Feb; 65(2):239-42. PubMed ID: 19942618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4-Quinolone bactericidal mechanisms.
    Howard BM; Pinney RJ; Smith JT
    Arzneimittelforschung; 1993 Oct; 43(10):1125-9. PubMed ID: 7505585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraphagocytic bactericidal activity of bacterial DNA gyrase inhibitors against Serratia marcescens.
    Traub WH
    Chemotherapy; 1984; 30(6):379-86. PubMed ID: 6097410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incomplete cross-resistance of nalidixic and pipemidic acid-resistant variants of Serratia marcescens against ciprofloxacin, enoxacin, and norfloxacin.
    Traub WH
    Chemotherapy; 1985; 31(1):34-9. PubMed ID: 3156026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The synergic effects of quinolones and oral cephem antibiotics on Serratia marcescens.
    Otsuki M; Nishino T
    J Antimicrob Chemother; 1996 Nov; 38(5):771-6. PubMed ID: 8961046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoroquinolone resistance of Serratia marcescens: sucrose, salicylate, temperature, and pH induction of phenotypic resistance.
    Begic S; Worobec EA
    Can J Microbiol; 2007 Nov; 53(11):1239-45. PubMed ID: 18026218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro antibacterial activity of piperacillin/quinolone combinations].
    Soussy CJ; Leclercq R; Duval J
    Pathol Biol (Paris); 1988 May; 36(5):357-60. PubMed ID: 3136421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative bacteriologic activity of norfloxacin, ofloxacin and pefloxacin against 320 Gram-negative bacilli resistant and non-resistant to nalidixic acid and cephalosporins].
    Croize J; Le Noc P; Bryskier A; Robert J
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):564-8. PubMed ID: 3937128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency and expression of mutational resistance to the 4-quinolone antibacterials.
    Smith JT
    Scand J Infect Dis Suppl; 1986; 49():115-23. PubMed ID: 3547618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of subinhibitory levels of aminoglycosides and fluoroquinolines on hydrophobicity and motility of Serratia marcescens].
    Majtán V; Majtánová L
    Epidemiol Mikrobiol Imunol; 2001 Feb; 50(1):26-30. PubMed ID: 11233670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant prevention concentration of nalidixic acid, ciprofloxacin, clinafloxacin, levofloxacin, norfloxacin, ofloxacin, sparfloxacin or trovafloxacin for Escherichia coli under different growth conditions.
    Linde HJ; Lehn N
    J Antimicrob Chemother; 2004 Feb; 53(2):252-7. PubMed ID: 14688048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of suprainhibitory concentrations of quinolones on hydrophobicity and motility of Serratia marcescens.
    Majtán V; Majtánová L
    Microbios; 2000; 102(402):79-88. PubMed ID: 10885498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative antibacterial activity of fleroxacin: selection frequencies and outer membrane proteins of resistant mutants].
    Cullmann W; Dechène M; Stieglitz M
    Immun Infekt; 1988 Aug; 16(4):152-8. PubMed ID: 3141267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning, sequencing, and characterization of the SdeAB multidrug efflux pump of Serratia marcescens.
    Kumar A; Worobec EA
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1495-501. PubMed ID: 15793131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salicylate induction of phenotypic resistance to quinolones in Serratia marcescens.
    Berlanga M; Viñas M
    J Antimicrob Chemother; 2000 Aug; 46(2):279-82. PubMed ID: 10933653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoroquinolone resistance of Serratia marcescens: involvement of a proton gradient-dependent efflux pump.
    Kumar A; Worobec EA
    J Antimicrob Chemother; 2002 Oct; 50(4):593-6. PubMed ID: 12356807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of the 4-quinolones with other antibacterials.
    Lewin CS; Smith JT
    J Med Microbiol; 1989 Jul; 29(3):221-7. PubMed ID: 2664184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic susceptibility of Serratia marcescens and Serratia liquefaciens.
    Traub WH
    Chemotherapy; 2000; 46(5):315-21. PubMed ID: 10965096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of antimicrobial drugs and combined phagocytic/serum bactericidal activity of defibrinated human blood against Serratia marcescens. I. Cotrimoxazole, nalidixic acid, nitrofurantoin, and trimethoprim.
    Traub WH
    Chemotherapy; 1982; 28(5):369-80. PubMed ID: 6754280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.